EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Poly( d,l -lactide- co -glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells

Pornpattra Rattanaseth iD, Kanlaya Katewongsa iD, Kitti Intuyod, Somchai Pinlaor iD, Raynoo Thanan, Chadamas Sakonsinsiri iD

ACS Applied Bio Materials · 21.07.2025 · 8 (7) · 6055-6065

DOI: 10.1021/acsabm.5c00628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 18.06.2025. Verfasst von Pornpattra Rattanaseth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. Hauptthemen laut MEDLINE: Doxorubicin, Cholangiocarcinoma, Nanoparticles, Polylactic Acid-Polyglycolic Acid Copolymer. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Khon Kaen University, Cholangiocarcinoma Research Institute, Khon Kaen University, Faculty of Medicine, Khon Kaen University, Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCholangiocarcinomaNanoparticlesPolylactic Acid-Polyglycolic Acid CopolymerAntibiotics, AntineoplasticDrug Resistance, NeoplasmBiocompatible MaterialsBile Duct NeoplasmsDrug CarriersHumansParticle SizeMaterials TestingDrug Screening Assays, AntitumorCell SurvivalCell ProliferationSurface PropertiesCell Line, TumorDrug LiberationDose-Response Relationship, Drug

Stichwörter der Autor:innen

CholangiocarcinomaDoxorubicinDrug deliveryDrug resistancePLGAPolymeric nanoparticles

Substanzen

DoxorubicinPolylactic Acid-Polyglycolic Acid CopolymerAntibiotics, AntineoplasticBiocompatible MaterialsDrug Carriers

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

ORCID-Profile: Pornpattra Rattanaseth, Kanlaya Katewongsa, Somchai Pinlaor, Chadamas Sakonsinsiri

Förderung

  • Khon Kaen University
  • Cholangiocarcinoma Research Institute, Khon Kaen University
  • Faculty of Medicine, Khon Kaen University, Thailand

Zitieren

APA

Rattanaseth, P., Katewongsa, K., Intuyod, K., Pinlaor, S., Thanan, R., & Sakonsinsiri, C. (2025). Poly( d,l -lactide- co -glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells. ACS Applied Bio Materials, 8(7), 6055-6065. https://doi.org/10.1021/acsabm.5c00628

Vancouver

Rattanaseth P, Katewongsa K, Intuyod K, Pinlaor S, Thanan R, Sakonsinsiri C. Poly( d,l -lactide- co -glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells. ACS Applied Bio Materials. 2025;8(7):6055-6065. doi:10.1021/acsabm.5c00628

BibTeX
@article{Rattanaseth2025,
  author = {Rattanaseth, Pornpattra and Katewongsa, Kanlaya and Intuyod, Kitti and Pinlaor, Somchai and Thanan, Raynoo and Sakonsinsiri, Chadamas},
  title = {Poly( d,l -lactide- co -glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  volume = {8},
  number = {7},
  pages = {6055--6065},
  doi = {10.1021/acsabm.5c00628}
}
Kostenlos starten →